These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

507 related items for PubMed ID: 19213040

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Fibroblast growth factor 2 retargeted adenovirus has redirected cellular tropism: evidence for reduced toxicity and enhanced antitumor activity in mice.
    Gu DL, Gonzalez AM, Printz MA, Doukas J, Ying W, D'Andrea M, Hoganson DK, Curiel DT, Douglas JT, Sosnowski BA, Baird A, Aukerman SL, Pierce GF.
    Cancer Res; 1999 Jun 01; 59(11):2608-14. PubMed ID: 10363982
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Inhibition of tumorigenicity and metastasis of human bladder cancer growing in athymic mice by interferon-beta gene therapy results partially from various antiangiogenic effects including endothelial cell apoptosis.
    Izawa JI, Sweeney P, Perrotte P, Kedar D, Dong Z, Slaton JW, Karashima T, Inoue K, Benedict WF, Dinney CP.
    Clin Cancer Res; 2002 Apr 01; 8(4):1258-70. PubMed ID: 11948141
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. In situ generation of pseudotyped retroviral progeny by adenovirus-mediated transduction of tumor cells enhances the killing effect of HSV-tk suicide gene therapy in vitro and in vivo.
    Okada T, Caplen NJ, Ramsey WJ, Onodera M, Shimazaki K, Nomoto T, Ajalli R, Wildner O, Morris J, Kume A, Hamada H, Blaese RM, Ozawa K.
    J Gene Med; 2004 Mar 01; 6(3):288-99. PubMed ID: 15026990
    [Abstract] [Full Text] [Related]

  • 9. A novel bystander effect involving tumor cell-derived Fas and FasL interactions following Ad.HSV-tk and Ad.mIL-12 gene therapies in experimental prostate cancer.
    Hall SJ, Canfield SE, Yan Y, Hassen W, Selleck WA, Chen SH.
    Gene Ther; 2002 Apr 01; 9(8):511-7. PubMed ID: 11948376
    [Abstract] [Full Text] [Related]

  • 10. Granulocyte-macrophage colony-stimulating factor in a combination gene therapy strategy for head and neck cancer.
    Day KV, Li D, Liu S, Guo M, O'Malley BW.
    Laryngoscope; 2001 May 01; 111(5):801-6. PubMed ID: 11368071
    [Abstract] [Full Text] [Related]

  • 11. Enhanced antitumor effects of a bicistronic adenovirus vector expressing both herpes simplex virus thymidine kinase and monocyte chemoattractant protein-1 against hepatocellular carcinoma.
    Tsuchiyama T, Kaneko S, Nakamoto Y, Sakai Y, Honda M, Mukaida N, Kobayashi K.
    Cancer Gene Ther; 2003 Apr 01; 10(4):260-9. PubMed ID: 12679798
    [Abstract] [Full Text] [Related]

  • 12. The role of the E1B 55 kDa gene product in oncolytic adenoviral vectors expressing herpes simplex virus-tk: assessment of antitumor efficacy and toxicity.
    Wildner O, Morris JC.
    Cancer Res; 2000 Aug 01; 60(15):4167-74. PubMed ID: 10945625
    [Abstract] [Full Text] [Related]

  • 13. Rat adenocarcinoma cell line infected with an adenovirus carrying a novel herpes-simplex virus-thymidine kinase suicide gene construct dies by apoptosis upon treatment with ganciclovir.
    Chu QD, Sun L, Li J, Byrnes K, Chervenak D, DeBenedetti A, Mathis JM, Li BD.
    J Surg Res; 2007 Nov 01; 143(1):189-94. PubMed ID: 17950092
    [Abstract] [Full Text] [Related]

  • 14. Targeting of suicide gene delivery in pancreatic cancer cells via FGF receptors.
    Kleeff J, Fukahi K, Lopez ME, Friess H, Büchler MW, Sosnowski BA, Korc M.
    Cancer Gene Ther; 2002 Jun 01; 9(6):522-32. PubMed ID: 12032663
    [Abstract] [Full Text] [Related]

  • 15. eIF4E-targeted suicide gene therapy in a minimal residual mouse model for metastatic soft-tissue head and neck squamous cell carcinoma improves disease-free survival.
    Siegele B, Cefalu C, Holm N, Sun G, Tubbs J, Meschonat C, Odaka Y, DeBenedetti A, Ghali GE, Chu Q, Mathis JM, Li BD.
    J Surg Res; 2008 Jul 01; 148(1):83-9. PubMed ID: 18570935
    [Abstract] [Full Text] [Related]

  • 16. Enhanced anti-tumor effects of herpes simplex virus thymidine kinase/ganciclovir system by codelivering monocyte chemoattractant protein-1 in hepatocellular carcinoma.
    Sakai Y, Kaneko S, Nakamoto Y, Kagaya T, Mukaida N, Kobayashi K.
    Cancer Gene Ther; 2001 Oct 01; 8(10):695-704. PubMed ID: 11687892
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Studies on herpes simplex virus thymidine kinase gene and GCV system for treatment of human bladder carcinoma].
    He J, Chen Y, Li H, Lu Y, Yan Y, Tan X.
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2004 Jun 01; 21(3):428-32. PubMed ID: 15250149
    [Abstract] [Full Text] [Related]

  • 19. Cancer-specific targeting of an adenovirus-delivered herpes simplex virus thymidine kinase suicide gene using translational control.
    Mathis JM, Williams BJ, Sibley DA, Carroll JL, Li J, Odaka Y, Barlow S, Nathan CO, Li BD, DeBenedetti A.
    J Gene Med; 2006 Sep 01; 8(9):1105-20. PubMed ID: 16802401
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.